Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.
暂无分享,去创建一个
S. Body | E. Aikawa | D. Towler | K. Yutzey | L. Demer | M. Sadeghi | D. Mortlock | C. Giachelli | M. Rogers | G. Huggins | M. Hofmann-Bowman
[1] L. Marshall,et al. Calcific aortic stenosis , 2016, Nature Reviews Disease Primers.
[2] Magdi H Yacoub,et al. Expression of smooth muscle cell markers and co-activators in calcified aortic valves. , 2015, European heart journal.
[3] Thoralf M Sundt,et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.
[4] A. Vaidya,et al. Interactions between adrenal-regulatory and calcium-regulatory hormones in human health , 2014, Current opinion in endocrinology, diabetes, and obesity.
[5] Annette Lee,et al. Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cells. , 2014, Anticancer research.
[6] K. Yutzey,et al. Conserved transcriptional regulatory mechanisms in aortic valve development and disease. , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[7] Y. Bossé,et al. Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization. , 2014, Journal of the American College of Cardiology.
[8] M. Sandhu,et al. Lipoprotein(a) levels, genotype and incident aortic stenosis: a prospective Mendelian randomization study and replication in a case-control cohort , 2013 .
[9] B. Nordestgaard,et al. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. , 2013, Journal of the American College of Cardiology.
[10] J. Stone,et al. Cellular and Molecular Pathobiology of Cardiovascular Disease , 2014 .
[11] F. Schoen,et al. Calcific and Degenerative Heart Valve Disease , 2014 .
[12] C. Giachelli,et al. An Inducible, Ligand-Independent Receptor Activator of NF-κB Gene to Control Osteoclast Differentiation from Monocytic Precursors , 2013, PloS one.
[13] M. Puato,et al. Aortic valve calcification in chronic kidney disease. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] S. Colucci,et al. The Role of TNF-α and TNF Superfamily Members in the Pathogenesis of Calcific Aortic Valvular Disease , 2013, TheScientificWorldJournal.
[15] R. Bonow,et al. Transcatheter aortic valve replacement: current status and future directions. , 2013, Seminars in thoracic and cardiovascular surgery.
[16] P. Libby,et al. Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. , 2013, American heart journal.
[17] B. Carabello. Introduction to aortic stenosis. , 2013, Circulation research.
[18] Craig A Simmons,et al. Hemodynamic and cellular response feedback in calcific aortic valve disease. , 2013, Circulation research.
[19] R. Bonow,et al. Current management of calcific aortic stenosis. , 2013, Circulation research.
[20] D. Towler. Molecular and cellular aspects of calcific aortic valve disease. , 2013, Circulation research.
[21] R. Weiss,et al. Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models. , 2013, Circulation research.
[22] K. Yutzey,et al. Developmental Pathways in CAVD , 2013 .
[23] Jeffrey A. Jones,et al. Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease. , 2013, The Journal of thoracic and cardiovascular surgery.
[24] Elena Aikawa,et al. Macrophage-Derived Matrix Vesicles: An Alternative Novel Mechanism for Microcalcification in Atherosclerotic Plaques , 2013, Circulation research.
[25] Joshua D. Hutcheson,et al. MicroRNA in Cardiovascular Calcification: Focus on Targets and Extracellular Vesicle Delivery Mechanisms , 2013, Circulation research.
[26] C. Giachelli,et al. Vascular Calcification: An Update on Mechanisms and Challenges in Treatment , 2013, Calcified Tissue International.
[27] Kathleen F. Kerr,et al. Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.
[28] Y. Bossé,et al. High Expression of the Pi-Transporter SLC20A1/Pit1 in Calcific Aortic Valve Disease Promotes Mineralization through Regulation of Akt-1 , 2013, PloS one.
[29] S. Verma,et al. miRNA-141 is a novel regulator of BMP-2-mediated calcification in aortic stenosis. , 2012, The Journal of thoracic and cardiovascular surgery.
[30] K. Yutzey,et al. Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease. , 2012, Journal of molecular and cellular cardiology.
[31] C. Rapezzi,et al. The elusive link between aortic wall histology and echocardiographic anatomy in bicuspid aortic valve: implications for prophylactic surgery. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[32] E. V. van Beek,et al. Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients With Aortic Stenosis , 2012, Circulation.
[33] C. Otto,et al. Look more closely at the valve: imaging calcific aortic valve disease. , 2012, Circulation.
[34] R. Sacco,et al. Aortic valve calcification in mild primary hyperparathyroidism. , 2011, The Journal of clinical endocrinology and metabolism.
[35] S. Aakhus,et al. Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis , 2011, Journal of Internal Medicine.
[36] K. J. Grande-Allen,et al. Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .
[37] S. Leal,et al. Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1 , 2011, Nature Genetics.
[38] M. Henein,et al. Challenges in the management of severe asymptomatic aortic stenosis. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[39] C. Shanahan,et al. Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate , 2011, Circulation research.
[40] D. Towler,et al. The regulation of valvular and vascular sclerosis by osteogenic morphogens. , 2011, Circulation research.
[41] Craig A. Simmons,et al. Animal Models of Calcific Aortic Valve Disease , 2011, International journal of inflammation.
[42] Javier Bermejo,et al. Diet-Induced Aortic Valve Disease in Mice Haploinsufficient for the Notch Pathway Effector RBPJK/CSL , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[43] R. Nerem,et al. Discovery of Side- and Shear-Dependent miRNAs and mRNAs in Human Aortic Valvular Endothelial Cells , 2011 .
[44] T. Brady,et al. Imaging of the aortic valve using fluorodeoxyglucose positron emission tomography increased valvular fluorodeoxyglucose uptake in aortic stenosis. , 2011, Journal of the American College of Cardiology.
[45] R. Nerem,et al. Preferential Activation of SMAD1/5/8 on the Fibrosa Endothelium in Calcified Human Aortic Valves - Association with Low BMP Antagonists and SMAD6 , 2011, PloS one.
[46] R. Weiss,et al. Calcific Aortic Valve Stenosis: Methods, Models, and Mechanisms , 2011, Circulation research.
[47] E. Aikawa,et al. Molecular Imaging Insights Into Early Inflammatory Stages of Arterial and Aortic Valve Calcification , 2011, Circulation research.
[48] R. Levine,et al. Mitral Valve Endothelial Cells With Osteogenic Differentiation Potential , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[49] J. Horowitz,et al. Pathogenesis of aortic stenosis: not just a matter of wear and tear. , 2011, American journal of cardiovascular disease.
[50] R. Brooks,et al. Evidence for Active Regulation of Pro-Osteogenic Signaling in Advanced Aortic Valve Disease , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[51] A. Redaelli,et al. Biomechanical implications of the congenital bicuspid aortic valve: a finite element study of aortic root function from in vivo data. , 2010, The Journal of thoracic and cardiovascular surgery.
[52] Luis Luna-Zurita,et al. Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. , 2010, The Journal of clinical investigation.
[53] C. Salaün,et al. Identification of a Novel Transport-independent Function of PiT1/SLC20A1 in the Regulation of TNF-induced Apoptosis* , 2010, The Journal of Biological Chemistry.
[54] J. Mayer,et al. Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study. , 2010, Tissue engineering. Part C, Methods.
[55] Oscar L. Sierra,et al. Activation of Vascular Smooth Muscle Parathyroid Hormone Receptor Inhibits Wnt/&bgr;-Catenin Signaling and Aortic Fibrosis in Diabetic Arteriosclerosis , 2010, Circulation research.
[56] R. Weissleder,et al. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation , 2010, European heart journal.
[57] Ajit P Yoganathan,et al. Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner. , 2010, The American journal of pathology.
[58] D. Srivastava,et al. Altered microRNAs in bicuspid aortic valve: a comparison between stenotic and insufficient valves. , 2010, The Journal of heart valve disease.
[59] R. Kronmal,et al. Incidence and progression of aortic valve calcium in the Multi-ethnic Study of Atherosclerosis (MESA). , 2010, The American journal of cardiology.
[60] K. Teo,et al. Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.
[61] M. Kirby,et al. The role of secondary heart field in cardiac development. , 2009, Developmental biology.
[62] D. Srivastava,et al. Notch1 represses osteogenic pathways in aortic valve cells. , 2009, Journal of molecular and cellular cardiology.
[63] A. Levin,et al. Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[64] Eli J. Weinberg,et al. A Computational Model of Aging and Calcification in the Aortic Heart Valve , 2009, PloS one.
[65] Craig A Simmons,et al. Calcification by Valve Interstitial Cells Is Regulated by the Stiffness of the Extracellular Matrix , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[66] S. Young,et al. Lowering Plasma Cholesterol Levels Halts Progression of Aortic Valve Disease in Mice , 2009, Circulation.
[67] Ajit P Yoganathan,et al. Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. , 2009, Journal of the American College of Cardiology.
[68] P. Libby,et al. Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease , 2009, Circulation.
[69] Ajit P Yoganathan,et al. Altered Shear Stress Stimulates Upregulation of Endothelial VCAM-1 and ICAM-1 in a BMP-4– and TGF-&bgr;1–Dependent Pathway , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[70] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[71] M. Budoff,et al. Relationship of Metabolic Syndrome With Incident Aortic Valve Calcium and Aortic Valve Calcium Progression , 2009, Diabetes.
[72] Siew Yen Ho,et al. Structure and anatomy of the aortic root. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[73] T. Hisada,et al. The sinus of Valsalva relieves abnormal stress on aortic valve leaflets by facilitating smooth closure. , 2008, The Journal of thoracic and cardiovascular surgery.
[74] Frederick J. Schoen,et al. Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering , 2008, Circulation.
[75] C. Otto,et al. Calcific aortic stenosis--time to look more closely at the valve. , 2008, The New England journal of medicine.
[76] J. Chambers,et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.
[77] Bruce J Aronow,et al. Shared gene expression profiles in developing heart valves and osteoblast progenitor cells. , 2008, Physiological genomics.
[78] R. Weissleder,et al. Notch Signaling in Cardiovascular Disease and Calcification , 2008, Current cardiology reviews.
[79] M. Budoff,et al. Soluble intercellular adhesion molecule-1 (sICAM-1) and aortic valve calcification in the multi-ethnic study of atherosclerosis (MESA). , 2008, Journal of Heart Valve Disease.
[80] M. Yacoub,et al. Localisation and function of nerves in the aortic root. , 2008, Journal of molecular and cellular cardiology.
[81] J. Kappes,et al. Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT Signaling* , 2008, Journal of Biological Chemistry.
[82] M. Budoff,et al. Ethnic differences between extra-coronary measures on cardiac computed tomography: multi-ethnic study of atherosclerosis (MESA). , 2008, Atherosclerosis.
[83] P. Libby,et al. Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury , 2008, Circulation.
[84] G. Nickenig,et al. Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves. , 2008, The Journal of heart valve disease.
[85] M. Yacoub,et al. The need for a global perspective on heart valve disease epidemiology. The SHVD working group on epidemiology of heart valve disease founding statement. , 2008, The Journal of heart valve disease.
[86] C. Simmons,et al. Mechanobiology of the aortic heart valve. , 2008, The Journal of heart valve disease.
[87] A. Yoganathan,et al. Heart valve function: a biomechanical perspective , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.
[88] Timur Shtatland,et al. Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo , 2007, Circulation.
[89] V. Joag,et al. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. , 2007, The American journal of pathology.
[90] M. Budoff,et al. Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[91] R. Bonow,et al. Calcific aortic stenosis: an update , 2007, Nature Clinical Practice Cardiovascular Medicine.
[92] Ralph Weissleder,et al. Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor , 2007, Circulation.
[93] S. Takai,et al. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits. , 2007, Journal of the American College of Cardiology.
[94] J. Zamorano,et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. , 2007, Journal of the American College of Cardiology.
[95] Ralph Weissleder,et al. Multimodality Molecular Imaging Identifies Proteolytic and Osteogenic Activities in Early Aortic Valve Disease , 2007, Circulation.
[96] C. Otto,et al. Indications for Aortic Valve Replacement in Aortic Stenosis , 2007, Journal of intensive care medicine.
[97] C. Eisenberg,et al. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. , 2007, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[98] K. Griendling,et al. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. , 2007, American journal of physiology. Cell physiology.
[99] Mark L. Johnson,et al. Diseases of Wnt signaling , 2007, Reviews in Endocrine and Metabolic Disorders.
[100] Hans Clevers,et al. Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.
[101] Vasilis Ntziachristos,et al. Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo , 2006, Circulation.
[102] J. Després,et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. , 2006, Journal of the American College of Cardiology.
[103] Robert M Nerem,et al. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. , 2006, Tissue engineering.
[104] R. Bonow,et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. , 2006, Journal of the American College of Cardiology.
[105] F. Schoen,et al. Human Semilunar Cardiac Valve Remodeling by Activated Cells From Fetus to Adult: Implications for Postnatal Adaptation, Pathology, and Tissue Engineering , 2006, Circulation.
[106] Robert M. Nerem,et al. Transcriptional Profiles of Valvular and Vascular Endothelial Cells Reveal Phenotypic Differences: Influence of Shear Stress , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[107] A. Yoganathan,et al. Differential immediate-early gene responses to elevated pressure in porcine aortic valve interstitial cells. , 2006, The Journal of heart valve disease.
[108] D. Levy,et al. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. , 2006, Journal of the American Society of Nephrology : JASN.
[109] F. Guilak,et al. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. , 2006, American journal of physiology. Heart and circulatory physiology.
[110] B. Lüderitz,et al. Cells of primarily extra-valvular origin in degenerative aortic valves and bioprostheses. , 2005, European heart journal.
[111] S. Hagl,et al. Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification. , 2005, International journal of molecular medicine.
[112] R. Derner,et al. The bone morphogenic protein. , 2005, Clinics in podiatric medicine and surgery.
[113] D. Srivastava,et al. Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.
[114] Kristi S Anseth,et al. Activation of valvular interstitial cells is mediated by transforming growth factor-beta1 interactions with matrix molecules. , 2005, Matrix biology : journal of the International Society for Matrix Biology.
[115] S. Stock,et al. Atorvastatin Inhibits Hypercholesterolemia-Induced Calcification in the Aortic Valves via the Lrp5 Receptor Pathway , 2005, Circulation.
[116] Y. Suematsu,et al. Age-associated aortic stenosis in apolipoprotein E-deficient mice. , 2005, Journal of the American College of Cardiology.
[117] Frederick J Schoen,et al. Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[118] B. Iung,et al. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. , 2005, European heart journal.
[119] Rosario V. Freeman,et al. Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.
[120] R. Prescott,et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.
[121] Su‐Li Cheng,et al. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. , 2005, The Journal of clinical investigation.
[122] Craig A. Simmons,et al. Spatial Heterogeneity of Endothelial Phenotypes Correlates With Side-Specific Vulnerability to Calcification in Normal Porcine Aortic Valves , 2005, Circulation research.
[123] S. Hagl,et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[124] Christopher K Breuer,et al. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. , 2004, Tissue engineering.
[125] E. Mohler. Mechanisms of aortic valve calcification. , 2004, The American journal of cardiology.
[126] M. Mäyränpää,et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. , 2004, Journal of the American College of Cardiology.
[127] Frederick J Schoen,et al. Clinical pulmonary autograft valves: pathologic evidence of adaptive remodeling in the aortic site. , 2004, The Journal of thoracic and cardiovascular surgery.
[128] M. Schemper,et al. Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis , 2004, Circulation.
[129] Frederick J Schoen,et al. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. , 2004, The Journal of heart valve disease.
[130] H. Reichenspurner,et al. Angiogenic activation of valvular endothelial cells in aortic valve stenosis. , 2004, Experimental cell research.
[131] L. Leinwand,et al. Valvular Myofibroblast Activation by Transforming Growth Factor-&bgr;: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease , 2004, Circulation research.
[132] W. Hörl. The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[133] Robert M Nerem,et al. Unique Morphology and Focal Adhesion Development of Valvular Endothelial Cells in Static and Fluid Flow Environments , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[134] L. Hofbauer,et al. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. , 2004, JAMA.
[135] S. Hagl,et al. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. , 2004, The Journal of heart valve disease.
[136] P. Dijke,et al. New insights into TGF-β–Smad signalling , 2004 .
[137] F. Baaijens,et al. Collagen fibers reduce stresses and stabilize motion of aortic valve leaflets during systole. , 2004, Journal of biomechanics.
[138] K. Alitalo,et al. Specific Induction of tie1 Promoter by Disturbed Flow in Atherosclerosis-Prone Vascular Niches and Flow-Obstructing Pathologies , 2004, Circulation research.
[139] G. De Visscher,et al. Molecular and functional characterization of ovine cardiac valve-derived interstitial cells in primary isolates and cultures. , 2003, Tissue engineering.
[140] P. Raggi,et al. Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. , 2004, The Journal of heart valve disease.
[141] C. Hill,et al. New insights into TGF-beta-Smad signalling. , 2004, Trends in biochemical sciences.
[142] S. Hagl,et al. Receptor activator of nuclear factor κB ligand and osteoprotegerin regulate aortic valve calcification , 2004 .
[143] M. Nanes. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. , 2003, Gene.
[144] K. Rogers,et al. Smoothelin-positive cells in human and porcine semilunar valves , 2003, Histochemistry and Cell Biology.
[145] T. Salo,et al. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. , 2003, Human pathology.
[146] Philippe Ravaud,et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.
[147] M. Schultz,et al. Evidence of woven bone formation in heart valve disease. , 2003, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[148] A. Tajik,et al. Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype , 2003, Circulation.
[149] Magdi H. Yacoub,et al. The cardiac valve interstitial cell. , 2003, The international journal of biochemistry & cell biology.
[150] R. Levy,et al. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. , 2003, The Annals of thoracic surgery.
[151] P. Faggiano,et al. Progression of aortic valve sclerosis to aortic stenosis. , 2003, The American journal of cardiology.
[152] E. Picano,et al. Aortic valve sclerosis is associated with systemic endothelial dysfunction. , 2003, Journal of the American College of Cardiology.
[153] M. Enriquez-Sarano,et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. , 2002, Journal of the American College of Cardiology.
[154] I. Kronzon,et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. , 2002, Archives of internal medicine.
[155] C. Otto,et al. Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma , 2002, Circulation.
[156] P. Raggi,et al. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. , 2002, Kidney international.
[157] R. Bonow,et al. Atorvastatin Inhibits Hypercholesterolemia-Induced Cellular Proliferation and Bone Matrix Production in the Rabbit Aortic Valve , 2002, Circulation.
[158] Stephen W Carmichael,et al. Localization of Caveolin 1 in Aortic Valve Endothelial Cells Using Antigen Retrieval , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[159] Frederick J Schoen,et al. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. , 2002, The Journal of heart valve disease.
[160] M. Budoff,et al. HMG CoA reductase inhibitor (statin) and aortic valve calcium , 2002, The Lancet.
[161] P. Libby,et al. Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves , 2001, Circulation.
[162] M. Lauer,et al. Effect of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors on the Progression of Calcific Aortic Stenosis , 2001, Circulation.
[163] W. Aronow,et al. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. , 2001, The American journal of cardiology.
[164] R. Natarajan,et al. Diabetes-induced accelerated atherosclerosis in swine. , 2001, Diabetes.
[165] Y. Soini,et al. Expression of MMP2, MMP9, MT1‐MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart , 2001, The Journal of pathology.
[166] C. Otto,et al. Why is there discordance between calcific aortic stenosis and coronary artery disease? , 2001, Heart.
[167] A. Tajik,et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. , 2001, The Journal of heart valve disease.
[168] Emile R. Mohler,et al. Bone Formation and Inflammation in Cardiac Valves , 2001, Circulation.
[169] W G Henderson,et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. , 2000, Journal of the American College of Cardiology.
[170] M. Schemper,et al. Predictors of outcome in severe, asymptomatic aortic stenosis. , 2000, The New England journal of medicine.
[171] Jianglin Fan,et al. Cholesterol-fed and transgenic rabbit models for the study of atherosclerosis. , 2000, Journal of atherosclerosis and thrombosis.
[172] D. Stewart,et al. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. , 2000, Circulation.
[173] K. Müller,et al. Expression of endothelial cell adhesion molecules on heart valves: up‐regulation in degeneration as well as acute endocarditis , 2000, The Journal of pathology.
[174] M. Yacoub,et al. Asymmetric redirection of flow through the heart , 2000, Nature.
[175] M. Sturek,et al. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[176] Bonnie K. Lind,et al. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. , 1999, The New England journal of medicine.
[177] R. Levy,et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. , 1999, The Journal of heart valve disease.
[178] J. Thyberg,et al. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[179] W. Edwards,et al. Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases. , 1999, Mayo Clinic proceedings.
[180] H. Hultgren. Osteitis deformans (Paget's disease) and calcific disease of the heart valves. , 1998, The American journal of cardiology.
[181] C M Otto,et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. , 1997, Circulation.
[182] Catherine M. Otto,et al. Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .
[183] E. Mohler,et al. Detection of osteopontin in calcified human aortic valves. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[184] Bonnie K. Lind,et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. , 1997, Journal of the American College of Cardiology.
[185] J. Taipale,et al. Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[186] M R de Leval,et al. Innervation of human atrioventricular and arterial valves. , 1996, Circulation.
[187] C. Otto,et al. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[188] A. Gotlieb,et al. Cell biology of valvular interstitial cells. , 1996, The Canadian journal of cardiology.
[189] Y Imai,et al. Regulation of the aortic valve opening. In vivo dynamic measurement of aortic valve orifice area. , 1995, The Journal of thoracic and cardiovascular surgery.
[190] A. Gown,et al. Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies , 1994, Circulation.
[191] J. Heikkilä,et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. , 1993, Journal of the American College of Cardiology.
[192] J Rapacz,et al. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. , 1991, The American journal of pathology.
[193] D J Wheatley,et al. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. , 1991, The New England journal of medicine.
[194] M. Kirby,et al. Role of Neural Crest in Congenital Heart Disease , 1990, Circulation.
[195] M. Simionescu,et al. Cellular events in the development of valvular atherosclerotic lesions induced by experimental hypercholesterolemia. , 1987, Atherosclerosis.
[196] W. Aronow,et al. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. , 1987, The American journal of cardiology.
[197] Deck Jd,et al. Endothelial cell orientation on aortic valve leaflets , 1986 .
[198] M. Thubrikar,et al. Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. , 1986, The American journal of cardiology.
[199] M. Thubrikar,et al. Comparison of the in vivo and in vitro mechanical properties of aortic valve leaflets. , 1986, The Journal of thoracic and cardiovascular surgery.
[200] J. Deck,et al. Endothelial cell orientation on aortic valve leaflets. , 1986, Cardiovascular research.
[201] H. Hultgren,et al. Noninvasive evaluation of the severity of aortic stenosis in adult patients. , 1984, American heart journal.
[202] M. Thubrikar,et al. Patterns and pathogenesis of calcification in pathologic human aortic valves. , 1984, Current surgery.
[203] M. Thubrikar,et al. The cyclic changes and structure of the base of the aortic valve. , 1980, American heart journal.
[204] M. Thubrikar,et al. The mechanism of opening of the aortic valve. , 1979, The Journal of thoracic and cardiovascular surgery.
[205] N. Fowler,et al. Clinical aspects of acquired valvular heart disease. , 1979, Seminars in roentgenology.
[206] W. Roberts,et al. The Structure of the Aortic Valve in Clinically Isolated Aortic Stenosis: An Autopsy Study of 162 Patients Over 15 Years of Age , 1970, Circulation.
[207] O. Jaffee. The development of the arterial outflow tract in the chick embryo heart , 1967, The Anatomical record.
[208] A. PelaezGomez. Calcific aortic stenosis , 1959 .
[209] H. A. Braun,et al. The importance of high-pitched squeaking systolic murmur in the diagnosis of aortic stenosis and calcification of the aortic valve. , 1951, The New England journal of medicine.